NeuroOne Medical Technologies (NASDAQ:NMTC) Posts Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTC) posted its quarterly earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative return on equity of 276.12% and a negative net margin of 308.51%.

NeuroOne Medical Technologies Stock Up 4.5 %

Shares of NASDAQ:NMTC opened at $0.79 on Wednesday. The firm’s 50 day simple moving average is $0.82 and its 200-day simple moving average is $0.84. NeuroOne Medical Technologies has a one year low of $0.55 and a one year high of $1.72.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.